We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

TQ Therapeutics

TQ Therapeutics is developing a novel platform for the production of cell therapeutics.

Latest Content

Researchers analyzing data during T-cell isolation research in a high-tech laboratory.

Product News

Deal Aims To Speed Scalable Cell Therapy Manufacturing

An exclusive development deal integrates affinity based cell isolation into an automated system that rapidly extracts T cells from blood or apheresis. The approach aims to boost manufacturing efficiency and speed for cell gene therapies.

Two biopharma researchers collaborating in a modern laboratory, reviewing data on a tablet with lab equipment and microscopes around them.

Product News

TQ Therapeutics GmbH Announces Acquisition of Juno Therapeutics GmbH

TQ Therapeutics acquires Juno Therapeutics GmbH, expanding its cell therapy platform and access to key intellectual property.

Never miss a story

with the Breaking Science News daily newsletter